USP7 and breast carcinoma: Combination of Usp7 knockdown and PI3K inhibition showed an additional cell growth impairment compared to PI3K-inhibitor-only treated cells; an effect that was most prominent in human breast cancer cells and upon use of PI3K-inhibitors at EC10 (Figure 6F).